Epigenetic regulation of wound healing and fibrosis

Current Opinion in Rheumatology

Volumn 25, Issue 1, 2013, Pages 101-107

  Mann, Jelena ^a   Mann, Derek A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Chromatin; DNA methylation; epigenetic regulation; fibrosis; microRNA; wound healing

Indexed keywords

3 DEAZANEPLANOCIN A; 5 AZA 2' DEOXYCYTIDINE; HISTONE DEACETYLASE INHIBITOR; MICRORNA; UNTRANSLATED RNA;

APOPTOSIS; CELL DIFFERENTIATION; CHROMATIN; DNA METHYLATION; EPIGENETICS; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENETIC REGULATION; HUMAN; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; WOUND HEALING;

DNA METHYLATION; EPIGENESIS, GENETIC; FIBROSIS; GENETIC THERAPY; HISTONES; HUMANS; MICRORNAS; WOUND HEALING;

EID: 84871207597     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835b13e1     Document Type: Review

References (40)

1. Chu AS, Diaz R, Hui JJ, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of he-patic fibrosis. Hepatology 2011; 53:1685-1695.
2. Scholten D, Osterreicher CH, Scholten A, et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 2010; 139:987-998.
3. Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180:1340-1355.
4. Wynn TA, Ramalingam TR. Mechanisms offibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18:1028-1040.
5. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88:125-172.
6. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:1655-1669.
7. Kisseleva T, Cong M, Paik Y, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109:9448-9453.
8. Troeger JS, Mederacke I, Gwak GY, et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012; 143:1073. e22-1083. e22.
9. Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Essential role of Me CP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol 2011; 178:1500-1508.
10. Mann J, Chu DC, Maxwell A, et al. Me CP2 controlsan epigenetic pathwaythat promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010; 138:705-714; 14 e1-14 e4.
11. Zhang Y, Wu L, Wang Y, et al. Protective roleofestrogen-induced mi RNA-29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem 2012; 287:14851-14862.
12. Kwiecinski M, Elfimova N, Noetel A, et al. Expression of platelet-derived growth factor-c and insulin-like growth factor I in hepatic stellate cells is inhibited by mi R-29. Lab Invest 2012; 92:978-987.
13. Wang B, Komers R, Carew R, et al. Suppression of micro RNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012; 23:252-265.
14. Kwiecinski M, Noetel A, Elfimova N, et al. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by mi RNA-29 induction. PLo S One 2011; 6:e24568.
15. Xiao J, Meng XM, Huang XR, et al. Mi R-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 2012; 20:1251-1260.
16. Li N, Cui J, Duan X, et al. Suppression of type i collagen expression by mi R-29bvia PI3K, AKT, and SP1 pathway in human Tenon'sfibroblasts. Invest Ophthalmol Vis Sci 2012; 53:1670-1678.
17. Xu J, Wu W, Zhang L, et al. The roleof micro RNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes 2012. doi: 10. 2337/db12-0145 [Epub ahead of print].
18. He Y, Huang C, Sun X, et al. Micro RNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 2012; 24:1923-1930.
19. Madhyastha R, Madhyastha H, Nakajima Y, et al. Micro RNA signature in diabetic wound healing: promotive role of mi R-21 in fibroblast migration. Int Wound J 2012; 9:355-361.
20. Pastar I, Khan AA, Stojadinovic O, et al. Induction of specific micro RNAs inhibits cutaneous wound healing. J Biol Chem 2012; 287:29324-29335.
21. Bertero T, Gastaldi C, Bourget-Ponzio I, et al. Mi R-483-3p controls proliferation in wounded epithelial cells. FASEB J 2011; 25:3092-3105.
22. Kashiyama K, Mitsutake N, Matsuse M, et al. Mi R-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 2012; 132:1597-1604.
23. Lakner AM, Steuerwald NM, Walling TL, et al. Inhibitory effects of micro RNA 19bin hepatic stellate cell-mediated fibrogenesis. Hepatology 2012; 56:300-310.
24. Chen C, Wu CQ, Zhang ZQ, et al. Lossof expression ofmi R-335 isimplicated in hepatic stellate cell migration and activation. Exp Cell Res 2011; 317:1714-1725.
25. Iizuka M, Ogawa T, Enomoto M, et al. Induction of microrna-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair 2012; 5:12.
26. Ogawa T, Enomoto M, Fujii H, et al. Micro RNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 2012; 61:1600-1609.
27. Meng F, Glaser SS, Francis H, et al. Epigenetic regulation of mi R-34a expression in alcoholic liver injury. Am J Pathol 2012; 181:804-81 7.
28. Jazbutyte V, Fiedler J, Kneitz S, et al. Micro RNA-22 increasessenescenceand activates cardiac fibroblasts in the aging heart. Age (Dordr) 2012. doi: 10. 1007/s11357-012-9407-9.
29. Aurora AB, Mahmoud AI, Luo X, et al. Micro RNA-214 protects the mouse heart from ischemic injury by controlling ca(2)(+) overload and cell death. J Clin Invest 2012; 122:1222-1232.
30. Huang Y, Dai Y, Zhang J, et al. Circulating micro RNAs as potential bio-markersforsmoking-related interstitialfibrosis. Biomarkers 2012; 1 7:435-440.
31. Nakashima T, Jinnin M, Yamane K, et al. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 2012; 188:3573-3583.
32. Sampson HW, Chaput CD, Brannen J, et al. Alcohol induced epigenetic perturbations during the inflammatory stage of fracture healing. Exp Biol Med (Maywood) 2011; 236:1389-1401.
33. Komatsu Y, Waku T, Iwasaki N, et al. Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med Genomics 2012. doi: 10. 1186/1755-8794-5-5.
34. Rabinovich EI, Kapetanaki MG, Steinfeld I, et al. Global methylation patterns in idiopathic pulmonaryfibrosis. PLo S One 2012; 7:e33770.
35. Perugorria MJ, Wilson CL, Zeybel M, et al. Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdiffer-entiation. Hepatology 2012; 56:1129-1139.
36. Yang MD, Chiang YM, Higashiyama R, et al. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology 2012; 55:1271-1281.
37. Zeybel M, Hardy T, Wong YK, et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med 2012; 18:1369-1377.
38. Zhou P, Lu Y, Sun XH. Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting Me CP2. Mol Vis 2011; 17:2717-2723.
39. Karen J, Rodriguez A, Friman T, et al. Effects of the histone deacetylase inhibitor valproic acid on human pericytes in vitro. PLo S One 2011; 6:e24954.
40. Kramer M, Dees C, Huang J, et al. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann Rheum Dis 2012. doi: 10. 1136/annrheumdis-2012-201615.